A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2001
10/24/2001	EP0809698B1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
10/24/2001	EP0775142B1 Substituted o6 -benzylguanines
10/24/2001	EP0721957B1 Compound ge3
10/24/2001	EP0593754B1 Peptides of human papilloma virus for use in human t cell response inducing compositions
10/24/2001	CN1319140A Recombinant CELO virus and CELO virus DNA
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319137A Keratinocyte derived interferon
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases
10/24/2001	CN1319131A Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
10/24/2001	CN1319100A Isoquinoline derivatives with angiogenesis inhibiting activity
10/24/2001	CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1319090A Novel substuted indolimones, their preparation process and use as medicine
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319083A 5,6-Dihydronaphthalenyl derivatives haivng retionoid-like activity
10/24/2001	CN1319019A i(ex vivo) treatment of allogeneic and xanogeneic T-cells with gp39 antagonists
10/24/2001	CN1319013A Pharmaceutical agents for treatment of parkinson's diseae, ADHD and microadenomas
10/24/2001	CN1319011A Tumor tissue accumulation enhancers for drugs
10/24/2001	CN1319010A Treatment regimen for administration of phenylacetylgluta-mine, phenylacetylisoglutamize, and/or phenylacetate
10/24/2001	CN1319009A Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/24/2001	CN1318645A Liver cancer related gene and its application
10/24/2001	CN1318411A Hysteromyoma capsule
10/24/2001	CN1318384A Oral Chinese medicine liquid for treating digestive system cancer
10/24/2001	CN1318377A Hepatosis treating Chinese medicine
10/24/2001	CN1073557C Vitamin-D amide derivatives
10/24/2001	CN1073415C Application of sulfamides compound in preparation of anticancer medicine
10/23/2001	US6307092 Potent ocular hypotensives and are particularly suited for the management of glaucoma.
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307068 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
10/23/2001	US6307051 2-alkylidene hydroxycoumaranone derivatives
10/23/2001	US6307022 Def
10/23/2001	US6306911 Enzyme inhibitors
10/23/2001	US6306902 Oxaliplatin formulations
10/23/2001	US6306900 Enteric coated pharmaceutical compositions
10/23/2001	US6306897 Calanolides for inhibiting BTK
10/23/2001	US6306886 Solid polymorph anticoagulants
10/23/2001	US6306879 Isotonic glucose solution
10/23/2001	US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001	US6306871 Iodonitrobenzamide derivatives as anticarcinogenic, antitumor agents and viricides
10/23/2001	US6306868 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives
10/23/2001	US6306865 Pharmaceutically active benzoquinazoline compounds
10/23/2001	US6306854 Chemical compounds
10/23/2001	US6306851 Cyclocarbamate and cyclic amide derivatives
10/23/2001	US6306844 Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
10/23/2001	US6306833 Methods and compositions for inducing tumor-specific cytotoxicity
10/23/2001	US6306819 Method for regulating size of vascularized normal tissue
10/23/2001	US6306663 Controlling protein levels in eucaryotic organisms
10/23/2001	US6306655 Antisense inhibition of C/EBP alpha expression
10/23/2001	US6306653 Peptide for use in diagnosis, prevention and treatment of mammary gland cancer
10/23/2001	US6306393 Administering to subject having a b-cell related malignancy a therapeutic composition comprising a pharmaceutically acceptable carrier and a combination of at least one naked anti-cd19 antibody and an anfi-cd20 antibody
10/23/2001	US6306388 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
10/23/2001	CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/23/2001	CA2080343C 5-benzyl barbiturate derivatives
10/23/2001	CA2040058C Alpha-mannosidase and fucosidase inhibitors
10/18/2001	WO2001077378A2 Diagnosis of diseases associated with dna adducts
10/18/2001	WO2001077377A2 Diagnosis of diseases associated with dna replication by assessing dna methylation
10/18/2001	WO2001077376A2 Diagnosis of diseases associated with metastasis
10/18/2001	WO2001077375A2 Diagnosis of diseases associated with gene regulation
10/18/2001	WO2001077360A2 Methods for ansamitocin production
10/18/2001	WO2001077358A2 Herpes viruses for immune modulation
10/18/2001	WO2001077342A1 Multivalent antibodies and uses therefor
10/18/2001	WO2001077338A2 Human protein kinases and protein kinase-like enzymes
10/18/2001	WO2001077326A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	WO2001077325A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077308A1 A new polypeptide - human quinone reductase 18 and the polynucleotide encoding it
10/18/2001	WO2001077303A2 Human ovarian mesothelial cells and methods of isolation and uses thereof
10/18/2001	WO2001077294A2 Hpv-specific short-mers
10/18/2001	WO2001077287A2 A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide
10/18/2001	WO2001077181A2 Anti-rhesus d monoclonal antibodies
10/18/2001	WO2001077179A1 Proteins with a high immunoreactivity and a method for the production thereof
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077164A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
10/18/2001	WO2001077163A1 A novel polypeptide-human cell differenciation transcription factor 16 and the polynucleotide encoding said polypeptide
10/18/2001	WO2001077162A1 A novel polypeptide-human sodium pump subunit 12 of and the polynucleotide encoding said polypeptide
10/18/2001	WO2001077150A2 Serine-threonine kinase
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077147A2 New bromodomain protein
10/18/2001	WO2001077146A2 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	WO2001077145A2 Integrin binding peptide derivatives
10/18/2001	WO2001077139A1 8ss-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS
10/18/2001	WO2001077138A1 8β-SUBSTITUTED-11β-PENTYL- AND 11β-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077116A1 Inhibitors of prenyl-protein transferase
10/18/2001	WO2001077115A1 Antitumoral ecteinascidin derivatives
10/18/2001	WO2001077110A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
10/18/2001	WO2001077107A1 Oxazole derivatives and their uses as tyrosine kinase inhibitors
10/18/2001	WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001	WO2001077102A1 Macrocyclic chelants for metallopharmaceuticals
10/18/2001	WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001	WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001	WO2001077092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/18/2001	WO2001077089A1 New neurokinin antagonists for use as medicaments
10/18/2001	WO2001077087A1 Novel compounds
10/18/2001	WO2001077085A1 Quinazoline compounds
10/18/2001	WO2001077073A1 Cathepsin cysteine protease inhibitors
10/18/2001	WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments

1 ... 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 ... 2211